Open AccessTherapeutic efficacy of pertussis hyperimmune gamma globulin
Author(s) -
M E Sukhareva,
N. M. Bulatov,
M. S. Petrova,
R. G. Mukhutdinova,
L. M. Zorina,
G. G. Akhmadullina,
G. P. Gritsenko,
M. I. Elmanova,
L. I. Isachenko,
E. V. Dudyshkina,
M. G. Akhmetova,
N. Sh. Akhmetzyanova
Publication year - 1981
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj79614
Subject(s) - whooping cough , medicine , gamma globulin , bordetella pertussis , pediatrics , drug , intensive care medicine , immunology , pharmacology , antibody , vaccination , biology , genetics , bacteria
Pertussis hyperimmune -globulin made by Kazan Scientific Research Institute of Experimental Medicine is a specific drug. Its effectiveness has been studied in 56 out of 120 sick children. It has been found that it has a beneficial therapeutic effect in uncomplicated whooping cough, reduces the severity and duration of the course of pertussis infection. It is recommended for use in severe whooping cough, mainly in children of "high risk" (under the age of one year and older in the presence of a burdened premorbid background).